Literature DB >> 8206433

Modulatory effect of piperine on benzo[a]pyrene cytotoxicity and DNA adduct formation in V-79 lung fibroblast cells.

C Y Chu1, J P Chang, C J Wang.   

Abstract

Piperine, a major component of black pepper and long peppers, has been reported previously to have an effect on the activation and deactivation of some exogenous substances. In the present study, piperine was found to promote DNA damage and cytotoxicity induced by benzo[a]pyrene (B[a]P) in cultured V-79 lung fibroblast cells. The V-79 cells were treated with a non-toxic dose of piperine (1-20 microM) plus 10 microM B[a]P, or pretreated with piperine for 30 min or 2 hr prior to the administration of 10 microM B[a]P. B[a]P cytotoxicity was potentiated significantly by piperine under each experimental condition. The relative plating efficiency (RPE) was 71% when V-79 cells were exposed to 10 microM B[a]P alone. When the culture was exposed to B[a]P plus piperine or pretreated with piperine for 30 min prior to the administration of B[a]P, the RPE values were 63 and 44% (P < 0.001), respectively. Pretreatment with piperine for 2 hr had no significant effect (P > 0.05). Furthermore, the lowest activities (P < 0.05) of glutathione S-transferase (GST) and uridine diphosphate glucuronyl transferase (UDP-GTase) of piperine-treated V-79 cells occurred 30 min to 1 hr after the piperine pretreatment. Pretreatment of V-79 cells with piperine also caused an increase in the covalent binding of B[a]P-diol-epoxide to DNA, 2.3 times greater than that of the V-79 cells without piperine treatment. These results suggest that the promotion by piperine of B[a]P-induced cytotoxicity in V-79 lung fibroblast cells is due to mechanisms that decrease the activities of GST and UDP-GTase and increase the formation of a B[a]P-DNA adduct.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206433     DOI: 10.1016/0278-6915(94)90076-0

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  Oral supplementation of piperine leads to altered phase II enzymes and reduced DNA damage and DNA-protein cross links in Benzo(a)pyrene induced experimental lung carcinogenesis.

Authors:  Karuppaiyah Selvendiran; Syed Mumtaz Banu; Dhanapal Sakthisekaran
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

Review 2.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

3.  Anticonvulsant effect of piperine ameliorates memory impairment, inflammation and oxidative stress in a rat model of pilocarpine-induced epilepsy.

Authors:  Ke Mao; Ding Lei; Heng Zhang; Chao You
Journal:  Exp Ther Med       Date:  2016-12-27       Impact factor: 2.447

4.  Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway.

Authors:  Yi Lin; Jianping Xu; Hehe Liao; Lu Li; Lei Pan
Journal:  Tumour Biol       Date:  2013-11-24

5.  Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models.

Authors:  Jun Soo Bang; Da Hee Oh; Hyun Mi Choi; Bong-Jun Sur; Sung-Jig Lim; Jung Yeon Kim; Hyung-In Yang; Myung Chul Yoo; Dae-Hyun Hahm; Kyoung Soo Kim
Journal:  Arthritis Res Ther       Date:  2009-03-30       Impact factor: 5.156

Review 6.  Piperine and Its Metabolite's Pharmacology in Neurodegenerative and Neurological Diseases.

Authors:  Shofiul Azam; Ju-Young Park; In-Su Kim; Dong-Kug Choi
Journal:  Biomedicines       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.